Federal Register Notice: FDA is making available a draft guidance for industry entitled Advisory Committee Meetings — Preparation and Public Availability of Information Given to Advisory Committee Members. The guidance is intended to provide information to industry sponsors, applicants, and petitioners on developing, preparing, or submitting briefing materials that will be given to advisory committee members as background information prior to open FDA advisory committee meetings. To download the draft document, click here. To view this notice, click here.